| Symbol | GENPF |
|---|---|
| Name | GENIX PHARMACEUTICALS CORP. |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | V6E 2E9 Canada BC 300 - 1055 West Hastings Street |
| Telephone | +1 7786288916 |
| Fax | — |
| — | |
| Website | https://genixpharm.com/ |
| Incorporation | CA |
| Incorporated On | 1993 |
| Employees | — |
| Fiscal Year | 10/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Buckley Dodds Parker LLP; |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: TSX Venture Exchange |
| CIK | 0001086113 |
| Description | Genix is an innovative Canadian life sciences company focused on the research, development, manufacture, licensing and sales of novel and innovative healthcare products, particularly proprietary over the counter nutraceuticals and generic pharmaceuticals that have been shown to deliver consistent and verifiable results in various therapeutic areas. Additional info from OTC: |
No news found.